Company Valuation: Glenmark Pharmaceuticals Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 124,718 131,124 270,463 434,866 601,567 736,171 - -
Change - 5.14% 106.27% 60.79% 38.33% 22.38% - -
Enterprise Value (EV) 1 150,223 162,699 263,786 442,540 595,740 723,918 714,456 705,856
Change - 8.3% 62.13% 67.76% 34.62% 21.52% -1.31% -1.2%
P/E 13.2x 44.1x -18x 41.5x 44.2x 32.9x 26.8x 23.5x
PBR 1.37x 1.38x 3.45x 4.91x 5.72x 5.92x 4.89x 4.12x
PEG - -0.6x 0x -0x 1.5x 0.5x 1.2x 1.7x
Capitalization / Revenue 1.01x 1.01x 2.29x 3.26x 3.54x 4.35x 3.91x 3.48x
EV / Revenue 1.22x 1.25x 2.23x 3.32x 3.51x 4.27x 3.8x 3.34x
EV / EBITDA 6.47x 7.14x 22.1x 18.8x 13x 20x 16.5x 14.5x
EV / EBIT 8.19x 9.76x 43x 23.7x 14.9x 24.1x 19.6x 17.4x
EV / FCF 47.2x 923x -22.7x -28.1x 28.5x 33.4x 41.1x 32.6x
FCF Yield 2.12% 0.11% -4.41% -3.56% 3.5% 2.99% 2.43% 3.06%
Dividend per Share 2 2.5 2.5 2.5 2.5 2.5 4.25 4.02 3.75
Rate of return 0.57% 0.54% 0.26% 0.16% 0.12% 0.16% 0.15% 0.14%
EPS 2 33.4 10.53 -53.22 37.11 48.24 79.35 97.43 110.9
Distribution rate 7.49% 23.7% -4.7% 6.74% 5.18% 5.36% 4.13% 3.38%
Net sales 1 123,409 129,901 118,131 133,217 169,825 169,387 188,066 211,257
EBITDA 1 23,203 22,784 11,953 23,514 45,724 36,253 43,263 48,791
EBIT 1 18,336 16,671 6,134 18,654 39,989 29,996 36,404 40,608
Net income 1 9,936 2,972 -15,017 10,471 13,619 21,961 27,354 30,536
Net Debt 1 25,505 31,575 -6,677 7,674 -5,827 -12,253 -21,715 -30,314
Reference price 2 442.00 464.70 958.45 1,541.05 2,131.70 2,608.50 2,608.50 2,608.50
Nbr of stocks (in thousands) 282,168 282,168 282,188 282,188 282,201 282,220 - -
Announcement Date 27/05/22 19/05/23 24/05/24 23/05/25 29/05/26 - - -
1INR in Million2INR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
34.79x4.34x20.26x0.16% 7.99B
40.47x13.71x29.06x0.49% 1,232B
39.91x6.7x18.85x1.95% 656B
36.46x8.39x17.35x2.41% 506B
21.68x5.25x13.15x2.48% 382B
97.8x5.62x23.94x2.47% 340B
23.54x5.68x13.81x2.8% 294B
23.52x4.72x13.42x1.86% 278B
22.92x7.08x13.01x2.27% 240B
-39.74x7.35x46.29x1.95% 210B
Average 30.13x 6.88x 20.91x 1.89% 415B
Weighted average by Cap. 35.44x 8.61x 21.92x 1.74%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Glenmark Pharmaceuticals Limited

Historical PBR trend

Valuation ratios - PBR - Glenmark Pharmaceuticals Limited

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Glenmark Pharmaceuticals Limited

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Glenmark Pharmaceuticals Limited


Year-on-year evolution of the Yield

Valuation ratios - Yield - Glenmark Pharmaceuticals Limited
  1. Stock Market
  2. Stocks
  3. GLENMARK Stock
  4. Valuation Glenmark Pharmaceuticals Limited